Personalized Cancer Vaccines

3 articles in this topic.

Complete Guides

Personalized Cancer Vaccines: Neoantigen Peptides

Neoantigen peptide vaccines use your tumor's unique mutations to train T cells against cancer. Here is where the clinical trials stand in 2026.

19 min read|Mar 20, 2026

All Articles

Personalized Cancer Vaccines

Peptide Vaccines Plus Checkpoint Inhibitors

How peptide cancer vaccines paired with PD-1 and CTLA-4 checkpoint inhibitors produce stronger antitumor immune responses than either therapy alone, with clinical trial data.

15 min read|Mar 25, 2026

Personalized Cancer Vaccines

KRAS Peptide Vaccines: Targeting Cancer's Top Mutation

KRAS mutations drive 25% of all cancers. Peptide vaccines targeting mutant KRAS are now in clinical trials for pancreatic, colorectal, and lung cancer.

13 min read|Mar 22, 2026